Indian Pharma Network
For Urgent Support
24/7 Free Support
Call US
+91 9891296838 / 9811747774
BRUKINSA (zanubrutinib) capsules, for oral use.
Initial U.S. Approval: 2019. Available in India.
BRUKINSA is a kinase inhibitor indicated for the treatment of adult patients with Waldenström's macroglobulinemia (WM), mantle cell lymphoma (MCL). Marginal zone lymphoma (MZL). Brand Name "BRUKINSA (zanubrutinib)" can be imported and made available on "Patient Name basis" treatment in India. If you have questions, please email IPN Support Team or Call Indian Pharma Network on +91 9891296838 (Mr. Tarun) / 9811747774 (Mr. Neeraj) for price list or cost in India.
Brukinsa (zanubrutinib) injection is used for the treatment of patients with mantle cell lymphoma (MCL)
BRUKINSA is a prescription medicine used to treat adults with: Waldenström's macroglobulinemia (WM). Mantle cell lymphoma (MCL) who have received at least one prior treatment for their cancer. Marginal zone lymphoma (MZL) when the disease has come back or did not respond to treatment and who have received at least one certain type of treatment.
Brukinsa (zanubrutinib) injection suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of Brukinsa (zanubrutinib) injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Brukinsa (zanubrutinib) injection tablets cost price in India.
The order for Brukinsa (zanubrutinib) injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Zanubrutinib, sold under the brand name Brukinsa, is for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. It was approved for medical use in the United States in November 2019. Zanubrutinib is classified as a Bruton's tyrosine kinase (BTK) inhibitor. It is administered orally.
BRUKINSA™ (zanubrutinib) capsules, for oral use Initial U.S. Approval: 2019
Generic Name: zanubrutinib
Capsules: 80 mg.
Brukinsa (zanubrutinib) injection tablets, for oral use is available.
Get In Touch
Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016
Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in
Brukinsa (zanubrutinib) injection suppliers in India
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Brukinsa (zanubrutinib) injection on prescription and Import License in Patient's Name only.
For overseas patients, Brukinsa (zanubrutinib) injection can be made available in Send your enquiry to find Brukinsa (zanubrutinib) injection in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
News / Update for Brukinsa (zanubrutinib) injection.
For Brukinsa (zanubrutinib) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
U.S. FDA Grants BeiGene’s BRUKINSA™ (zanubrutinib) Accelerated Approval to Treat Adult Patients with Mantle Cell Lymphoma Who Received at Least One Prior Therapy For More Details
FiercePharmaAsia—AZ-Daiichi's fast Enhertu nod; Astellas' 2 partnered approvals, CAR-T buy For More Details
Get Access To BRUKINSA (zanubrutinib) capsules In India
Indian Pharma Network (IPN), Delhi India is a leading Pharmaceutical Distributor / Supplier / Exporter / Importer of Anti-Cancer Medicines, used in mantle cell lymphoma (MCL) treatment. Brand Name "BRUKINSA (zanubrutinib) capsules" or Generic Name "zanubrutinib capsules" can be imported for personal use under "patient name basis" treatment in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India. Contact us at urgent@indianpharmanetwork.co.in or call/WhatsApp at +91 9891296838 / 9811747774 to get access as per norms.
